<SEC-DOCUMENT>0000078003-19-000009.txt : 20190213
<SEC-HEADER>0000078003-19-000009.hdr.sgml : 20190213
<ACCEPTANCE-DATETIME>20190213171442
ACCESSION NUMBER:		0000078003-19-000009
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20190213
DATE AS OF CHANGE:		20190213

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gemphire Therapeutics Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89598
		FILM NUMBER:		19598629

	BUSINESS ADDRESS:	
		STREET 1:		17199 N. LAUREL PARK DRIVE
		STREET 2:		SUITE 401
		CITY:			LIVONIA
		STATE:			MI
		ZIP:			48152
		BUSINESS PHONE:		248-980-6538

	MAIL ADDRESS:	
		STREET 1:		17199 N. LAUREL PARK DRIVE
		STREET 2:		SUITE 401
		CITY:			LIVONIA
		STATE:			MI
		ZIP:			48152

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PFIZER INC
		CENTRAL INDEX KEY:			0000078003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				135315170
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		235 E 42ND ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		2125732323

	MAIL ADDRESS:	
		STREET 1:		235 E 42ND ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PFIZER CHARLES & CO INC
		DATE OF NAME CHANGE:	19710908
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>gem13a1.htm
<DESCRIPTION>SCHEDULE 13G AMENDMENT 1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sA7976FFC41219BB19E11D965A8618C8D"></a></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">UNITED STATES <br>SECURITIES AND EXCHANGE COMMISSION <br>WASHINGTON, D.C. 20549</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SCHEDULE 13G</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">UNDER THE SECURITIES EXCHANGE ACT OF 1934 <br>(Amendment No. 1)*</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Gemphire Therapeutics Inc.</font><font style="font-family:inherit;font-size:12pt;">&#32;<br>(Name of Issuer)</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Common Stock, par value $0.001 per share</font><font style="font-family:inherit;font-size:12pt;">&#32;<br>(Title of Class of Securities)</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">36870A108</font><font style="font-family:inherit;font-size:12pt;">&#32;<br>(CUSIP Number)</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">December 31, 2018</font><font style="font-family:inherit;font-size:12pt;">&#32;<br>(Date of Event Which Requires Filing of this Statement)</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;<br>Check the appropriate box to designate the rule pursuant to which this Schedule <br>is filed:</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">&#32;<br>|_ |&#160; Rule 13d-1(b) <br>|X| &#160;Rule 13d-1(c) <br>|_ | &#160;Rule 13d-1(d)</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">&#32;<br>*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">&#32;<br>The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CUSIP No.&#160;&#160;36870A108 <br>-------------------------------------------------------------------------------- <br>1) Names of Reporting Persons. PFIZER INC. <br>I.R.S. Identification Nos. of Above Persons (entities only) 13-5315170 <br>-------------------------------------------------------------------------------- <br>2) Check the Appropriate Box if a Member of a Group (See Instructions) <br>(a) |_| <br>(b) |_| <br>--------------------------------------------------------------------------------</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">3) SEC Use Only <br></font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">-------------------------------------------------------------------------------- <br>4) Citizenship or Place of Organization <br>Delaware <br>--------------------------------------------------------------------------------</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:88.67521367521367%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:27%;"></td><td style="width:73%;"></td></tr><tr><td rowspan="4" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NUMBER OF <br>SHARES  <br>BENEFICIALLY  <br>OWNED BY EACH REPORTING <br>PERSON WITH:</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5. Sole Voting Power &#160;675,250 shares of Common Stock, $0.001 par value per share ("Common Stock")</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6. Shared Voting Power &#160;0</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7. Sole Dispositive Power&#160;675,250 shares of Common Stock</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">8. Shared Dispositive Power 0</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">-------------------------------------------------------------------------------- <br>9) Aggregate Amount Beneficially Owned by Each Reporting Person&#160; 675,250 shares of Common Stock <br>10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares <br>(See Instructions) |_| <br>11) Percent of Class Represented by Amount in Item 9&#160;&#160;&#160;&#160;&#160; 4.73%</font><font style="font-family:inherit;font-size:10pt;">(1)</font><font style="font-family:inherit;font-size:12pt;">&#32;<br>12) Type of Reporting Person (See Instructions)&#160;&#160; CO</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ITEM 1. <br>(A) NAME OF ISSUER: Gemphire Therapeutics Inc. <br>(B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICE:&#160;&#160;17199 N. Laurel Park Drive, Suite&#160;401, Livonia, MI, 48512 <br>ITEM 2.  <br>(A) NAME OF PERSONS FILING: This statement is being filed by Pfizer Inc., a Delaware corporation ("Pfizer")  <br>(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR IF NONE, RESIDENCE: The principal address of&#160; Pfizer is 235 E. 42nd Street, New York, NY 10017. <br>(C) CITIZENSHIP: Delaware <br>(D) TITLE OF CLASS OF SECURITIES: Common Stock &#160;&#160; <br>(E) CUSIP NUMBER: &#160;36870A108 <br>ITEM 3.  <br>Not applicable.  <br>(a)&#160;</font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#32;Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).  <br>(b) </font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#32;Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).  <br>(c)&#160;</font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#32;Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). <br>(d)&#160;</font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#32;Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). <br>(e) </font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#32;An investment adviser in accordance with &#167;240.13d-1(b)(1)(ii)(E). <br>(f )&#160;</font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#160;An employee benefit plan or endowment fund in accordance with &#167;240.13d-1(b)(1)(ii)(F).  <br>(g) </font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#160;A parent holding company or control person in accordance with &#167;240.13d-1(b)(1)(ii)(G).&#160;&#160; <br>(h)&#160;</font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#32;A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).  <br>(i )&#160;</font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#32;A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). &#160;&#160; <br></font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(j) &#160;</font><font style="font-family:Wingdings;font-size:12pt;">&#168;</font><font style="font-family:inherit;font-size:12pt;">&#32;Group, in accordance with &#167;240.13d-1(b)(1)(ii)(J).</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font><font style="font-family:inherit;font-size:12pt;">ITEM 4. OWNERSHIP. <br>(a) Amount beneficially owned: 675,250&#160; Shares of Common Stock <br>(b) Percent of class: &#160;&#160;&#160; 4.73%</font><font style="font-family:inherit;font-size:10pt;">(1)</font><font style="font-family:inherit;font-size:12pt;">&#32;<br>(c) Number of shares as to which the person has:  <br>(i) Sole power to vote or to direct the vote: &#160;675,250 Shares of Common Stock <br>(ii) Shared power to vote or to direct the vote: 0 <br>(iii) Sole power to dispose or to direct the disposition of: &#160;675,250 Shares of Common Stock <br>(iv) Shared power to dispose or to direct the disposition of:&#160;&#160;&#160;0 </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">(1)</font><font style="font-family:inherit;font-size:12pt;">&#32;The ownership percentage of the Reporting Person has been calculated based on 14,265,411 shares of Common Stock outstanding as of November 5, 2018 as set forth in the Issuer&#8217;s Quarterly Report on Form 10-Q for the period ended September 30, 2018, filed with the Securities and Exchange Commission on November 8, 2018.&#160;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">|X|.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">Not applicable.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">ITEM 7. &#160;IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY <br>Not applicable.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP <br>Not applicable.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">ITEM 9. NOTICE OF DISSOLUTION OF GROUP <br>Not applicable.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">ITEM 10. CERTIFICATION.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">&#32;<br>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any trans</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">action having that purpose or effect.</font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;<br>&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Signature</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">&#32;<br>Dated: February 13, 2019</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">PFIZER INC.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">&#32;<br>By: /s/ Susan Grant <br>Name: Susan Grant <br>Title: Assistant Secretary</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
